New-onset atrial fibrillation after recent coronary stenting: Warfarin or non-vitamin K-antagonist oral anticoagulants to be added to aspirin and clopidogrel? A viewpoint. [electronic resource]
Producer: 20160609Description: 133-8 p. digitalISSN:- 1874-1754
- Anticoagulants -- therapeutic use
- Antithrombins -- therapeutic use
- Aspirin -- therapeutic use
- Atrial Fibrillation -- surgery
- Clopidogrel
- Dabigatran -- therapeutic use
- Drug Combinations
- Factor Xa Inhibitors -- therapeutic use
- Humans
- Percutaneous Coronary Intervention
- Platelet Aggregation Inhibitors -- therapeutic use
- Pyrazoles -- therapeutic use
- Pyridones -- therapeutic use
- Stents
- Thrombosis -- prevention & control
- Ticlopidine -- analogs & derivatives
- Warfarin -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.